The FDA has approved Doptelet tablets to treat low blood platelet count in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure...
The post FDA approves Doptelet for thrombocytopenia in chronic liver disease appeared first on European Pharmaceutical Review.
Original Article: FDA approves Doptelet for thrombocytopenia in chronic liver disease